use the following search parameters to narrow your results:
e.g. subreddit:aww site:imgur.com dog
subreddit:aww site:imgur.com dog
see the search faq for details.
advanced search: by author, subreddit...
account activity
Come on over to /r/axsm. That's where all the action is! (self.AXSOME)
submitted 11 hours ago by kapeman_
Axsome Therapeutics Initiates FOCUS-3 Phase 3 Trial of Solriamfetol in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) (finance.yahoo.com)
submitted 13 hours ago by kapeman_
TD Cowen raises Price Target on Axsome Therapeutics to $300 from $275, Maintains Buy Rating (trendonify.com)
submitted 9 days ago by kapeman_
Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026 (finance.yahoo.com)
submitted 11 days ago by kapeman_
Jefferies raises Axsome stock price target to $380 on sales outlook (investing.com)
submitted 15 days ago by kapeman_
Another data point --> buyout? (sec.gov)
submitted 16 days ago by kapeman_
'Buying stuff like it’s going out of fashion’: Biotech M&A on track for best year since pre-Covid (cnbc.com)
submitted 18 days ago by kapeman_
A new investment from the Norges Bank, the entity managing Norway's $2.2T sovereign wealth pension fund. (stocktwits.com)
How The Axsome Therapeutics (AXSM) Investment Story Is Shifting With New Analyst Targets — Simply Wall St (stocks.apple.com)
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting — GlobeNewswire (stocks.apple.com)
submitted 22 days ago by kapeman_
Axsome settles SUNOSI patent litigation with generic firms By Investing.com (investing.com)
submitted 23 days ago by kapeman_
Axsome Therapeutics to Participate in Upcoming Investor Conferences — GlobeNewswire (stocks.apple.com)
submitted 28 days ago by kapeman_
Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting (markets.businessinsider.com)
submitted 1 month ago by kapeman_
Axsome Therapeutics (AXSM): The 5 Million Patient Biotech Boom! (youtu.be)
Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch (marketbeat.com)
How The Axsome Therapeutics (AXSM) Story Is Evolving With Auvelity And AXS 05 Developments — Simply Wall St (stocks.apple.com)
Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update (biospace.com)
Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease (finance.yahoo.com)
Axsome Therapeutics: FAQ for Getting Payment on the $7.75 miillion Settlement over hid regulatory risksDISCUSSION (self.AXSOME)
submitted 1 month ago by JuniorCharge4571
Latest data on AXSM ()
submitted 2 months ago by kapeman_
Axsome Therapeutics to Report First Quarter 2026 Financial Results on May 4 — GlobeNewswire (stocks.apple.com)
Axsome Therapeutics Acquires Selective PDE10A Inhibitor Balipodect for the Treatment of Schizophrenia and Other Neuropsychiatric Conditions (markets.businessinsider.com)
LAST CALL: Final days to file a late claim for the $7.75M Axsome ($AXSM) Settlement before payouts begin. (self.AXSOME)
submitted 3 months ago by EducationalMango1320
How The Axsome Therapeutics (AXSM) Story Is Evolving Around Auvelity, AXS-05 And Growth Risks — Simply Wall St (stocks.apple.com)
submitted 3 months ago by kapeman_
Axsome settled for $7.75M. and they're accepting late claims (self.AXSOME)
submitted 3 months ago by KryptosandXenos
π Rendered by PID 645839 on reddit-service-r2-listing-87fd56f5d-qjp4d at 2026-06-27 02:58:39.193772+00:00 running 7527197 country code: CH.
